{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:53:54Z","timestamp":1790776434412,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,29]]},"DOI":"10.7759\/cureus.55268","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:20:00Z","timestamp":1709245200000},"source":"Crossref","is-referenced-by-count":6,"title":["Navigating the Gut-Cardiac Axis: Understanding Cardiovascular Complications in Inflammatory Bowel Disease"],"prefix":"10.7759","author":[{"given":"Tanya","family":"Sinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zukhruf","family":"Zain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Faqeer Hussain","family":"Bokhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarosh","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taufiqa","family":"Reza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Eze-Odurukwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitwa","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Khaleel I KH","family":"Almadhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azlaan","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Reyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Inflammatory Bowel Disease","author":"McDowell C","year":"2023","unstructured":"McDowell C, Farooq U, Haseeb M. Inflammatory Bowel Disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref2","article-title":"Extraintestinal manifestations of inflammatory bowel disease","author":"Malik TF","year":"2023","unstructured":"Malik TF, Aurelio DM. Extraintestinal manifestations of inflammatory bowel disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro R","year":"2017","unstructured":"Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative colitis. Lancet. 2017, 389:1756-70. 10.1016\/S0140-6736(16)32126-2","journal-title":"Lancet"},{"key":"ref4","article-title":"Crohn disease","author":"Ranasinghe IR","year":"2023","unstructured":"Ranasinghe IR, Hsu R. Crohn disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref5","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"6","author":"Molodecky NA","year":"2010","unstructured":"Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2010, 6:339-46.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065186","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang R","year":"2023","unstructured":"Wang R, Li Z, Liu S, Zhang D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. BMJ Open. 2023, 13:e065186. 10.1136\/bmjopen-2022-065186","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000481","article-title":"Incidence trends of inflammatory bowel disease in a southern European country: a mirror of the western world?","volume":"13","author":"Santiago M","year":"2022","unstructured":"Santiago M, Stocker F, Ministro P, et al.. Incidence trends of inflammatory bowel disease in a southern European country: a mirror of the western world?. Clin Transl Gastroenterol. 2022, 13:e00481. 10.14309\/ctg.0000000000000481","journal-title":"Clin Transl Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izae020.086","article-title":"Trends of inflammatory bowel disease burden in the United States (1990-2019), projections of deaths to 2040: insights from the 2019 global burden of disease study","volume":"30","author":"Patel R","year":"2024","unstructured":"Patel R, Roy V, Kunhipurayil S, Patel KM, Elassar S, Sojitra V, Desai HD. Trends of inflammatory bowel disease burden in the United States (1990-2019), projections of deaths to 2040: insights from the 2019 global burden of disease study. Inflamm Bowel Dis. 2024, 30:41-2. 10.1093\/ibd\/izae020.086","journal-title":"Inflamm Bowel Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i38.6102","article-title":"Recent trends in the epidemiology of inflammatory bowel diseases: up or down?","volume":"12","author":"Lakatos PL","year":"2006","unstructured":"Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. World J Gastroenterol. 2006, 12:6102-8. 10.3748\/wjg.v12.i38.6102","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082661","article-title":"What links an increased cardiovascular risk and inflammatory bowel disease? a narrative review","volume":"13","author":"\u0141ykowska-Szuber L","year":"2021","unstructured":"\u0141ykowska-Szuber L, Rychter AM, Dudek M, et al.. What links an increased cardiovascular risk and inflammatory bowel disease? a narrative review. Nutrients. 2021, 13:2661. 10.3390\/nu13082661","journal-title":"Nutrients"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00300.2022","article-title":"Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms","volume":"325","author":"Xiao Y","year":"2023","unstructured":"Xiao Y, Powell DW, Liu X, Li Q. Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms. Am J Physiol Regul Integr Comp Physiol. 2023, 325:R193-211. 10.1152\/ajpregu.00300.2022","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150202161500","article-title":"Cardiovascular complications in inflammatory bowel disease","volume":"16","author":"Schicho R","year":"2015","unstructured":"Schicho R, Marsche G, Storr M. Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets. 2015, 16:181-8. 10.2174\/1389450116666150202161500","journal-title":"Curr Drug Targets"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032775","article-title":"Inflammatory bowel disease and associated cardiovascular disease outcomes: a systematic review","volume":"102","author":"Jaiswal V","year":"2023","unstructured":"Jaiswal V, Batra N, Dagar M, et al.. Inflammatory bowel disease and associated cardiovascular disease outcomes: a systematic review. Medicine (Baltimore). 2023, 102:e32775. 10.1097\/MD.0000000000032775","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/2047487318792952","article-title":"Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis","volume":"25","author":"Sun HH","year":"2018","unstructured":"Sun HH, Tian F. Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis. Eur J Prev Cardiol. 2018, 25:1623-31. 10.1177\/2047487318792952","journal-title":"Eur J Prev Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00639-y","article-title":"The risk of cardiovascular complications in inflammatory bowel disease","volume":"20","author":"Czubkowski P","year":"2020","unstructured":"Czubkowski P, Osiecki M, Szyma\u0144ska E, Kierku\u015b J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med. 2020, 20:481-91. 10.1007\/s10238-020-00639-y","journal-title":"Clin Exp Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2022.100316","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-a population-level analysis in the national health interview survey","volume":"9","author":"Nasir K","year":"2022","unstructured":"Nasir K, Acquah I, Dey AK, et al.. Inflammatory bowel disease and atherosclerotic cardiovascular disease in U.S. adults-a population-level analysis in the national health interview survey. Am J Prev Cardiol. 2022, 9:100316. 10.1016\/j.ajpc.2022.100316","journal-title":"Am J Prev Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.04.031","article-title":"Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases","volume":"16","author":"Aniwan S","year":"2018","unstructured":"Aniwan S, Pardi DS, Tremaine WJ, Loftus EV Jr. Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018, 16:1607-15.e1. 10.1016\/j.cgh.2018.04.031","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/ehjopen\/oeab029","article-title":"Inflammatory bowel disease and cardiovascular diseases: a concise review","volume":"2","author":"Wu H","year":"2022","unstructured":"Wu H, Hu T, Hao H, Hill MA, Xu C, Liu Z. Inflammatory bowel disease and cardiovascular diseases: a concise review. Eur Heart J Open. 2022, 2:oeab029. 10.1093\/ehjopen\/oeab029","journal-title":"Eur Heart J Open"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10204710","article-title":"Acute coronary syndromes and inflammatory bowel disease: the gut-heart connection","volume":"10","author":"Jaaouani A","year":"2021","unstructured":"Jaaouani A, Ismaiel A, Popa SL, Dumitrascu DL. Acute coronary syndromes and inflammatory bowel disease: the gut-heart connection. J Clin Med. 2021, 10:4710. 10.3390\/jcm10204710","journal-title":"J Clin Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/life12081113","article-title":"Ischemic heart disease in patients with inflammatory bowel disease: risk factors, mechanisms and prevention","volume":"12","author":"Jucan AE","year":"2022","unstructured":"Jucan AE, Gavrilescu O, Dranga M, Popa IV, Mihai BM, Prelipcean CC, Mihai C. Ischemic heart disease in patients with inflammatory bowel disease: risk factors, mechanisms and prevention. Life (Basel). 2022, 12:1113. 10.3390\/life12081113","journal-title":"Life (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i22.2788","article-title":"Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study","volume":"25","author":"Choi YJ","year":"2019","unstructured":"Choi YJ, Choi EK, Han KD, et al.. Increased risk of atrial fibrillation in patients with inflammatory bowel disease: A nationwide population-based study. World J Gastroenterol. 2019, 25:2788-98. 10.3748\/wjg.v25.i22.2788","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004305","article-title":"Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study","volume":"20","author":"Sun J","year":"2023","unstructured":"Sun J, Roelstraete B, Svennberg E, et al.. Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study. PLoS Med. 2023, 20:e1004305. 10.1371\/journal.pmed.1004305","journal-title":"PLoS Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1177\/1179546820955179","article-title":"An investigation into the association between inflammatory bowel disease and cardiac arrhythmias: an examination of the United States national inpatient sample database","volume":"14","author":"Mubasher M","year":"2020","unstructured":"Mubasher M, Syed T, Hanafi A, et al.. An investigation into the association between inflammatory bowel disease and cardiac arrhythmias: an examination of the United States national inpatient sample database. Clin Med Insights Cardiol. 2020, 14:1179546820955179. 10.1177\/1179546820955179","journal-title":"Clin Med Insights Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/diseases10040073","article-title":"Thromboembolic events in patients with inflammatory bowel disease: a comprehensive overview","volume":"10","author":"Gala D","year":"2022","unstructured":"Gala D, Newsome T, Roberson N, et al.. Thromboembolic events in patients with inflammatory bowel disease: a comprehensive overview. Diseases. 2022, 10:73. 10.3390\/diseases10040073","journal-title":"Diseases"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i40.6757","article-title":"Venous and arterial thromboembolism in patients with inflammatory bowel diseases","volume":"27","author":"Stadnicki A","year":"2021","unstructured":"Stadnicki A, Stadnicka I. Venous and arterial thromboembolism in patients with inflammatory bowel diseases. World J Gastroenterol. 2021, 27:6757-74. 10.3748\/wjg.v27.i40.6757","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2159","article-title":"Increased risk of stroke among patients with inflammatory bowel disease: a PRISMA-compliant meta-analysis","volume":"11","author":"Chen Y","year":"2021","unstructured":"Chen Y, Wang X. Increased risk of stroke among patients with inflammatory bowel disease: a PRISMA-compliant meta-analysis. Brain Behav. 2021, 11:e02159. 10.1002\/brb3.2159","journal-title":"Brain Behav"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"26","author":"Cheng K","year":"2020","unstructured":"Cheng K, Faye AS. Venous thromboembolism in inflammatory bowel disease. World J Gastroenterol. 2020, 26:1231-41. 10.3748\/wjg.v26.i12.1231","journal-title":"World J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010251","article-title":"Venous thromboembolism in patients with inflammatory bowel disease","volume":"13","author":"Dhaliwal G","year":"2023","unstructured":"Dhaliwal G, Patrone MV, Bickston SJ. Venous thromboembolism in patients with inflammatory bowel disease. J Clin Med. 2023, 13:251. 10.3390\/jcm13010251","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i12.3173","article-title":"Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment","volume":"20","author":"Papa A","year":"2014","unstructured":"Papa A, Gerardi V, Marzo M, Felice C, Rapaccini GL, Gasbarrini A. Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment. World J Gastroenterol. 2014, 20:3173-9. 10.3748\/wjg.v20.i12.3173","journal-title":"World J Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2019.00068","article-title":"Inflammatory bowel disease and superior mesenteric artery thromboembolism","volume":"18","author":"Nicolaides S","year":"2020","unstructured":"Nicolaides S, Vasudevan A, Langenberg DV. Inflammatory bowel disease and superior mesenteric artery thromboembolism. Intest Res. 2020, 18:130-3. 10.5217\/ir.2019.00068","journal-title":"Intest Res"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen L","year":"2018","unstructured":"Chen L, Deng H, Cui H, et al.. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018, 9:7204-18. 10.18632\/oncotarget.23208","journal-title":"Oncotarget"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/BF01300378","article-title":"Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease","volume":"37","author":"Stevens C","year":"1992","unstructured":"Stevens C, Walz G, Singaram C, et al.. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci. 1992, 37:818-26. 10.1007\/BF01300378","journal-title":"Dig Dis Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1295230","article-title":"The dual role of interleukin-6 in Crohn's disease pathophysiology","volume":"14","author":"Alhendi A","year":"2023","unstructured":"Alhendi A, Naser SA. The dual role of interleukin-6 in Crohn's disease pathophysiology. Front Immunol. 2023, 14:1295230. 10.3389\/fimmu.2023.1295230","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo A","year":"2010","unstructured":"Sandoo A, van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010, 4:302-12. 10.2174\/1874192401004010302","journal-title":"Open Cardiovasc Med J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-37078-6_8","article-title":"Vascular endothelial function","author":"Widlansky ME","year":"2015","unstructured":"Widlansky ME, Malik MA. Vascular endothelial function. PanVascular Medicine. Lanzer P (ed): Springer, Berlin, Heidelberg; 2015. 89-120. 10.1007\/978-3-642-37078-6_8"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i3.1067","article-title":"Endothelial dysfunction in inflammatory bowel diseases: pathogenesis, assessment and implications","volume":"22","author":"Cibor D","year":"2016","unstructured":"Cibor D, Domagala-Rodacka R, Rodacki T, Jurczyszyn A, Mach T, Owczarek D. Endothelial dysfunction in inflammatory bowel diseases: pathogenesis, assessment and implications. World J Gastroenterol. 2016, 22:1067-77. 10.3748\/wjg.v22.i3.1067","journal-title":"World J Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.5830\/CVJA-2011-068","article-title":"Endothelial dysfunction: the early predictor of atherosclerosis","volume":"23","author":"Mudau M","year":"2012","unstructured":"Mudau M, Genis A, Lochner A, Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012, 23:222-31. 10.5830\/CVJA-2011-068","journal-title":"Cardiovasc J Afr"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113179","article-title":"Endothelial dysfunction and arterial stiffness in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Wu H","year":"2022","unstructured":"Wu H, Xu M, Hao H, Hill MA, Xu C, Liu Z. Endothelial dysfunction and arterial stiffness in patients with inflammatory bowel disease: a systematic review and meta-analysis. J Clin Med. 2022, 11:3179. 10.3390\/jcm11113179","journal-title":"J Clin Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-200409000-00026","article-title":"C-reactive protein as a marker for inflammatory bowel disease","volume":"10","author":"Vermeire S","year":"2004","unstructured":"Vermeire S, Van Assche G, Rutgeerts P. C-reactive protein as a marker for inflammatory bowel disease. Inflamm Bowel Dis. 2004, 10:661-5. 10.1097\/00054725-200409000-00026","journal-title":"Inflamm Bowel Dis"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.3889\/oamjms.2019.526","article-title":"Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia","volume":"7","author":"Swastini DA","year":"2019","unstructured":"Swastini DA, Wiryanthini IA, Ariastuti NL, Muliantara A. Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia. Open Access Maced J Med Sci. 2019, 7:3887-90.","journal-title":"Open Access Maced J Med Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.100.1.96","article-title":"C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?","volume":"100","author":"Lagrand WK","year":"1999","unstructured":"Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation. 1999, 100:96-102. 10.1161\/01.cir.100.1.96","journal-title":"Circulation"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(00)02160-2","article-title":"Increased levels of homocysteine in patients with Crohn\u2019s disease are related to folate levels","volume":"95","author":"Chowers Y","year":"2000","unstructured":"Chowers Y, Sela BA, Holland R, Fidder H, Simoni FB, Bar-Meir S. Increased levels of homocysteine in patients with Crohn\u2019s disease are related to folate levels. Am J Gastroenterol. 2000, 95:3498-502. 10.1016\/S0002-9270(00)02160-2","journal-title":"Am J Gastroenterol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2891-14-6","article-title":"Role of homocysteine in the development of cardiovascular disease","volume":"14","author":"Ganguly P","year":"2015","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015, 14:6. 10.1186\/1475-2891-14-6","journal-title":"Nutr J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073464","article-title":"Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets","volume":"23","author":"Santana PT","year":"2022","unstructured":"Santana PT, Rosas SL, Ribeiro BE, Marinho Y, de Souza HS. Dysbiosis in inflammatory bowel disease: pathogenic role and potential therapeutic targets. Int J Mol Sci. 2022, 23:3464. 10.3390\/ijms23073464","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i30.4053","article-title":"Gut microbiota, inflammatory bowel disease and colorectal cancer","volume":"28","author":"Quaglio AE","year":"2022","unstructured":"Quaglio AE, Grillo TG, De Oliveira EC, Di Stasi LC, Sassaki LY. Gut microbiota, inflammatory bowel disease and colorectal cancer. World J Gastroenterol. 2022, 28:4053-60. 10.3748\/wjg.v28.i30.4053","journal-title":"World J Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.03.003","article-title":"The gut microbiome and thromboembolism","volume":"189","author":"Hasan RA","year":"2020","unstructured":"Hasan RA, Koh AY, Zia A. The gut microbiome and thromboembolism. Thromb Res. 2020, 189:77-87. 10.1016\/j.thromres.2020.03.003","journal-title":"Thromb Res"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13038","article-title":"Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide","volume":"128","author":"Zhu Y","year":"2020","unstructured":"Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS. 2020, 128:353-66. 10.1111\/apm.13038","journal-title":"APMIS"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal A","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes. 2021, 13:1-24. 10.1080\/19490976.2021.1897212","journal-title":"Gut Microbes"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R088989","article-title":"Microbial impact on cholesterol and bile acid metabolism: current status and future prospects","volume":"60","author":"Kriaa A","year":"2019","unstructured":"Kriaa A, Bourgin M, Potiron A, et al.. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res. 2019, 60:323-32. 10.1194\/jlr.R088989","journal-title":"J Lipid Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/nu15183970","article-title":"New insights into the pathogenesis of metabolic-associated fatty liver disease (MAFLD): gut-liver-heart crosstalk","volume":"15","author":"Yang K","year":"2023","unstructured":"Yang K, Song M. New insights into the pathogenesis of metabolic-associated fatty liver disease (MAFLD): gut-liver-heart crosstalk. Nutrients. 2023, 15:3970. 10.3390\/nu15183970","journal-title":"Nutrients"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11041016","article-title":"Fecal microbiota transplantation in inflammatory bowel disease","volume":"11","author":"Boicean A","year":"2023","unstructured":"Boicean A, Birlutiu V, Ichim C, Anderco P, Birsan S. Fecal microbiota transplantation in inflammatory bowel disease. Biomedicines. 2023, 11:1016. 10.3390\/biomedicines11041016","journal-title":"Biomedicines"},{"key":"ref52","article-title":"Fecal microbiota transplantation for inflammatory bowel disease","volume":"12","author":"Lopez J","year":"2016","unstructured":"Lopez J, Grinspan A. Fecal microbiota transplantation for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2016, 12:374-9.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238910","article-title":"Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis","volume":"15","author":"Caldeira LF","year":"2020","unstructured":"Caldeira LF, Borba HH, Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R. Fecal microbiota transplantation in inflammatory bowel disease patients: a systematic review and meta-analysis. PLoS One. 2020, 15:e0238910. 10.1371\/journal.pone.0238910","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-015-0044-2","article-title":"Thrombosis in inflammatory bowel diseases: what's the link?","volume":"13","author":"Giannotta M","year":"2015","unstructured":"Giannotta M, Tapete G, Emmi G, Silvestri E, Milla M. Thrombosis in inflammatory bowel diseases: what's the link?. Thromb J. 2015, 13:14. 10.1186\/s12959-015-0044-2","journal-title":"Thromb J"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020372","article-title":"Nutritional aspects in inflammatory bowel diseases","volume":"12","author":"Balestrieri P","year":"2020","unstructured":"Balestrieri P, Ribolsi M, Guarino MP, Emerenziani S, Altomare A, Cicala M. Nutritional aspects in inflammatory bowel diseases. Nutrients. 2020, 12:372. 10.3390\/nu12020372","journal-title":"Nutrients"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173824","article-title":"Nutrition, nutritional status, micronutrients deficiency, and disease course of inflammatory bowel disease","volume":"15","author":"Valvano M","year":"2023","unstructured":"Valvano M, Capannolo A, Cesaro N, et al.. Nutrition, nutritional status, micronutrients deficiency, and disease course of inflammatory bowel disease. Nutrients. 2023, 15:3824. 10.3390\/nu15173824","journal-title":"Nutrients"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/nu15081991","article-title":"Nutritional status and its detection in patients with inflammatory bowel diseases","volume":"15","author":"Jab\u0142o\u0144ska B","year":"2023","unstructured":"Jab\u0142o\u0144ska B, Mrowiec S. Nutritional status and its detection in patients with inflammatory bowel diseases. Nutrients. 2023, 15:1991. 10.3390\/nu15081991","journal-title":"Nutrients"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v13.i15.2150","article-title":"Effect of smoking on inflammatory bowel disease: is it disease or organ specific?","volume":"13","author":"Karban A","year":"2007","unstructured":"Karban A, Eliakim R. Effect of smoking on inflammatory bowel disease: is it disease or organ specific?. World J Gastroenterol. 2007, 13:2150-2.","journal-title":"World J Gastroenterol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.691480","article-title":"Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice","volume":"12","author":"Bruscoli S","year":"2021","unstructured":"Bruscoli S, Febo M, Riccardi C, Migliorati G. Glucocorticoid therapy in inflammatory bowel disease: mechanisms and clinical practice. Front Immunol. 2021, 12:691480. 10.3389\/fimmu.2021.691480","journal-title":"Front Immunol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.910623","article-title":"Impact of inflammatory bowel disease (IBD) and IBD medications on risk of hyperlipidemia and in vitro hepatic lipogenic-related gene expression: a population-based cohort study","volume":"9","author":"Tien N","year":"2022","unstructured":"Tien N, Wu TY, Lin CL, Wu CJ, Hsu CY, Fang YJ, Lim YP. Impact of inflammatory bowel disease (IBD) and IBD medications on risk of hyperlipidemia and in vitro hepatic lipogenic-related gene expression: a population-based cohort study. Front Med (Lausanne). 2022, 9:910623. 10.3389\/fmed.2022.910623","journal-title":"Front Med (Lausanne)"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i12.1779","article-title":"Obesity and novel management of inflammatory bowel disease","volume":"29","author":"Kim JH","year":"2023","unstructured":"Kim JH, Oh CM, Yoo JH. Obesity and novel management of inflammatory bowel disease. World J Gastroenterol. 2023, 29:1779-94. 10.3748\/wjg.v29.i12.1779","journal-title":"World J Gastroenterol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.10.001","article-title":"Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?","volume":"30","author":"Bigeh A","year":"2020","unstructured":"Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: does all inflammation lead to heart disease?. Trends Cardiovasc Med. 2020, 30:463-9. 10.1016\/j.tcm.2019.10.001","journal-title":"Trends Cardiovasc Med"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy164","article-title":"Cardiovascular risk profile among patients with inflammatory bowel disease: a population-based study of more than 100 000 individuals","volume":"13","author":"Aarestrup J","year":"2019","unstructured":"Aarestrup J, Jess T, Kobylecki CJ, Nordestgaard BG, Allin KH. Cardiovascular risk profile among patients with inflammatory bowel disease: a population-based study of more than 100 000 individuals. J Crohns Colitis. 2019, 13:319-23. 10.1093\/ecco-jcc\/jjy164","journal-title":"J Crohns Colitis"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa718","article-title":"Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis","volume":"60","author":"Corrales A","year":"2021","unstructured":"Corrales A, Vegas-Revenga N, Atienza-Mateo B, et al.. Combined use of QRISK3 and SCORE as predictors of carotid plaques in patients with rheumatoid arthritis. Rheumatology (Oxford). 2021, 60:2801-7. 10.1093\/rheumatology\/keaa718","journal-title":"Rheumatology (Oxford)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.794169","article-title":"Nutraceuticals for the treatment of IBD: current progress and future directions","volume":"9","author":"Ban QY","year":"2022","unstructured":"Ban QY, Liu M, Ding N, Chen Y, Lin Q, Zha JM, He WQ. Nutraceuticals for the treatment of IBD: current progress and future directions. Front Nutr. 2022, 9:794169. 10.3389\/fnut.2022.794169","journal-title":"Front Nutr"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/nu14204261","article-title":"Dietary interventions in inflammatory bowel disease","volume":"14","author":"Godala M","year":"2022","unstructured":"Godala M, Gaszy\u0144ska E, Zatorski H, Ma\u0142ecka-Wojciesko E. Dietary interventions in inflammatory bowel disease. Nutrients. 2022, 14:4261. 10.3390\/nu14204261","journal-title":"Nutrients"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2019.09.005","article-title":"Nutritional and dietary strategy in the clinical care of inflammatory bowel disease","volume":"119","author":"Hsieh MS","year":"2020","unstructured":"Hsieh MS, Hsu WH, Wang JW, et al.. Nutritional and dietary strategy in the clinical care of inflammatory bowel disease. J Formos Med Assoc. 2020, 119:1742-9. 10.1016\/j.jfma.2019.09.005","journal-title":"J Formos Med Assoc"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1124628","article-title":"IL-17 inhibitor-associated inflammatory bowel disease: a study based on literature and database analysis","volume":"14","author":"Deng Z","year":"2023","unstructured":"Deng Z, Wang S, Wu C, Wang C. IL-17 inhibitor-associated inflammatory bowel disease: a study based on literature and database analysis. Front Pharmacol. 2023, 14:1124628. 10.3389\/fphar.2023.1124628","journal-title":"Front Pharmacol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1089099","article-title":"JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases","volume":"10","author":"Herrera-deGuise C","year":"2023","unstructured":"Herrera-deGuise C, Serra-Ruiz X, Lastiri E, Borruel N. JAK inhibitors: a new dawn for oral therapies in inflammatory bowel diseases. Front Med (Lausanne). 2023, 10:1089099. 10.3389\/fmed.2023.1089099","journal-title":"Front Med (Lausanne)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111322","article-title":"The era of Janus Kinase inhibitors for inflammatory bowel disease treatment","volume":"22","author":"Kim JW","year":"2021","unstructured":"Kim JW, Kim SY. The era of Janus Kinase inhibitors for inflammatory bowel disease treatment. Int J Mol Sci. 2021, 22:11322. 10.3390\/ijms222111322","journal-title":"Int J Mol Sci"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i17.1920","article-title":"Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions","volume":"27","author":"Gubatan J","year":"2021","unstructured":"Gubatan J, Levitte S, Patel A, Balabanis T, Wei MT, Sinha SR. Artificial intelligence applications in inflammatory bowel disease: emerging technologies and future directions. World J Gastroenterol. 2021, 27:1920-35. 10.3748\/wjg.v27.i17.1920","journal-title":"World J Gastroenterol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07506-8","article-title":"Artificial intelligence for inflammatory bowel diseases (IBD); accurately predicting adverse outcomes using machine learning","volume":"67","author":"Zand A","year":"2022","unstructured":"Zand A, Stokes Z, Sharma A, van Deen WK, Hommes D. Artificial intelligence for inflammatory bowel diseases (IBD); accurately predicting adverse outcomes using machine learning. Dig Dis Sci. 2022, 67:4874-85. 10.1007\/s10620-022-07506-8","journal-title":"Dig Dis Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/231332-navigating-the-gut-cardiac-axis-understanding-cardiovascular-complications-in-inflammatory-bowel-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T22:20:05Z","timestamp":1709245205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/231332-navigating-the-gut-cardiac-axis-understanding-cardiovascular-complications-in-inflammatory-bowel-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":72,"URL":"https:\/\/doi.org\/10.7759\/cureus.55268","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}